Get Jra Longterm Outcome Study Form 2 - Rheumatology

Filling out the JRA Longterm Outcome Study Form 2 - Rheumatology online can be a straightforward process when you have a clear guide. This document is designed to help you accurately provide information about your child's condition and functional abilities, ensuring that their care can be appropriately managed.

Follow the steps to fill out the JRA Longterm Outcome Study Form 2 - Rheumatology online.

1. Press the ‘Get Form’ button to access the JRA Longterm Outcome Study Form 2 - Rheumatology and open it in your preferred online editor.
2. Begin by entering the date of the office visit and the patient’s name in the designated fields. Make sure to provide the first name, middle initial, and last name accurately.
3. Next, fill in the patient's date of birth and the date when this form is completed. This information is crucial for proper identification and record-keeping.
4. In Part 1 Ability Scale, carefully review each statement regarding the child's abilities over the past week. Select the response that best describes their experience by checking the corresponding box for 'All the time', 'Sometimes', or 'Almost never'.
5. After completing the ability scale, move to the section regarding aids or devices. Indicate whether your child has used various supportive devices by checking the appropriate box.
6. Proceed to the 'Help from Others' section, where you will check the categories for which your child requires assistance from another person. Mark 'No Help' or 'Some Help' as applicable.
7. Finally, address the pain scale question by marking on the provided line to indicate the severity of pain experienced by your child in the past week.
8. Once you have filled out all sections, review the form for accuracy. After ensuring that all necessary information is included, you can save changes, download, print, or share the completed form as needed.

Take the next step in managing your child's health by completing the JRA Longterm Outcome Study Form 2 - Rheumatology online today.